News
-
-
PRESS RELEASE
First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach
Pentixapharm starts Phase I/II trial treating leukemia with Lu177-PentixaTher, a targeted radiotherapy. Study aims to expand treatment options for hematologic malignancies -
-
-
-
PRESS RELEASE
Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Pixotope Technologies AS launches Pixotope Reveal, an AI-powered background segmentation tool revolutionizing live broadcast graphics integration. Enhances AR interaction, talent tracking, and sponsorship value -
-
-
-